Veeva Pulse Field Trends Report
As the pharmaceutical industry continues to adapt to HCP preferences and hybrid commercial models, it’s critical to stay on top of evolving field and HCP engagement trends.
Each quarter, the Veeva Pulse Field Trends Report provides unique insights into global and regional engagement trends based on analysis of 600 million HCP interactions across more than 80% of biopharmas worldwide.
See the InsightsHCPs start 30% of conversations with an inbound channel
As therapies become more precise and patient groups get smaller, HCPs often require on-demand access to resources – in the moment of need – to help patients. Inbound channels, like compliant chat, give HCPs immediate access to reps and resources while helping biopharmas build stronger relationships and improve the patient experience. HCPs start 30% of conversations with an inbound channel, and on average, their rep responds within five minutes by sending samples, scheduling meetings, or providing compliant content.
Inbound channels more than double digital engagement
HCPs are more selective than ever before. Most only meet with three or fewer biopharmas, and 84% prefer to maintain or increase virtual interactions with field teams. Inbound digital channels can more than double digital engagement with HCPs while keeping or increasing the overall volume of touchpoints.
Responding to HCPs in real-time improves interactions
By providing HCPs with information and resources when they need it, field teams can shift to a service-focused engagement model. This approach prioritizes the HCP and leads to more meaningful in-person touchpoints with responsive, real-time interactions in between meetings and in the moment of need.
Achieve commercial excellence in sales, medical, and marketing
Help your field teams engage HCPs at the right time with the right omnichannel mix.
Read Full Report Subscribe to Future ReportsRead previous trend reports
